Dear visitor of scilifelab.se

If this is your first visit to the website, we would like to ask for your help so we can improve the website navigation. Our aim is to make it easier for you and your colleagues to find the support you are looking for when you visit scilifelab.se in the near future. Please follow the link to our survey and answer the questions, it only takes 5 minutes.

Drug Discovery and Development


DDD 600x200pxl

 

The SciLifeLab Drug Discovery and Development platform offers integrated drug discovery efforts to the Swedish academic research community. We offer industry standard infrastructure, expertise, and strategic support to help progress projects towards a pre-clinical proof-of-concept. The drug leads can be either a small molecule drug or a human antibody therapeutic. Services are offered in the following areas:

  • Up to 80 hour free support to prepare your project as a drug discovery project, including an initial drug target product profile, and a lead generation/antibody selection strategy with progression plans
  • In collaboration with Chemical Biology Consortium Sweden, logistic solutions and data management for sharing of large number of compounds (SciLifeLab compound collection)/antibodies. For more details contact Åsa Slevin, asa.slevin@scilifelab.se
  • Protein production for assay development
  • Identification of binders from our IP free phage display library of human antibodies
  • Biochemical and cellular screening, both at single concentration in large compound libraries and to generate dose response data for iterative chemistry
  • Medicinal synthetic and computational chemistry
  • Analysis of drug metabolism and pharmacokinetics data for compounds and antibodies
  • Advanced analysis of in vitro pharmacology and systems pharmacology of compounds and antibodies
  • Biophysical characterization of molecular interaction between target and compounds or antibody

Importantly, the researcher/customer retains all rights and ownership during this process.

We encourage all academic researchers with an interest in turning their discoveries into cures for patients to contact us. For more information for how to start a project, please contact us via dddprojectproposal@scilifelab.se

For quarterly updates from the platform – sign up for our newsletter!

Previous newsletters:
#1, 2016
#2, 2016
#3, 2016

DDD Project portfolio_Q4_2016

 

Platform steering board

Håkan Billig, Chair (University of Gothenburg)
Tommy Olsson (Umeå University)
Mef Nilbert (Lund University)
Anna Sandström (AstraZeneca, ex-Vinnova)
Bo Öberg (Medivir)
Maria Jenmalm (Linköping University)
Kjell Sakariassen (KELLSA)

Platform directors
Per Arvidsson, Platform Director (Karolinska Institutet) per.arvidsson@scilifelab.se
Kristian Sandberg, Vice Platform Director (Uppsala Universitet) kristian.sandberg@scilifelab.uu.se